Balanced news tone
News Sentiment
AMGN sentiment intelligence
Amgen Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
54
Balanced news tone
26 relevant articles
News tone and price action are not far from neutral.
86/100 classification confidence.
directly relevant articles
high-authority source matches
-0.2% over one week, +8.9% over four weeks, trend active, and near fair-value range.
What If Amgen Stock's Patent Worries Are Hiding Its Real Growth Engine?
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
86/100 classification
One-week reaction
-0.2%
Price digesting
Trend fit
Trend active
8.9% over four weeks
Fair value
19.6%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
8
Neutral
17
Negative
1
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Market source
Direct company coverage
What If Amgen Stock's Patent Worries Are Hiding Its Real Growth Engine?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 18 Jun 2026 20:57
- Source
- Market source
MarketWatch
Direct company coverage
Amgen Inc. stock outperforms competitors despite losses on the day
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 18 Jun 2026 20:35
- Source
- MarketWatch
Market source
Direct company coverage
Amgen (AMGN) Sees a More Significant Dip Than Broader Market: Some Facts to Know
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 21:50
- Source
- Market source
MarketWatch
Direct company coverage
Amgen Inc. stock underperforms Wednesday when compared to competitors
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 20:35
- Source
- MarketWatch
TIKR.com
Direct company coverage
Amgen Stock’s Gross Margin Story in Q1 2026: What the Numbers Say About a $468 Target
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Jun 2026 14:05
- Source
- TIKR.com
Investing.com Nigeria
Direct company coverage
Mizuho raises Amgen stock price target to $303 on MariTide outlook
- Tone
- Positive 66/100
- Event
- Guidance
- Published
- 16 Jun 2026 11:44
- Source
- Investing.com Nigeria
simplywall.st
Direct company coverage
How Patent Setback and Drug Wins Will Impact Amgen (AMGN) Investors
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 11:37
- Source
- simplywall.st
Quiver Quantitative
Direct company coverage
Amgen Stock (AMGN) Opinions on Congressional Trade Disclosure
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jun 2026 14:04
- Source
- Quiver Quantitative
simplywall.st
Direct company coverage
Amgen (AMGN) Stock Valuation Looks Split Between Analyst Targets And DCF Upside
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 14 Jun 2026 06:19
- Source
- simplywall.st
Market source
Direct company coverage
Here’s Why Amgen (AMGN) is Among the 7 Best Longevity Stocks to Buy Now
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 13 Jun 2026 10:39
- Source
- Market source
simplywall.st
Direct company coverage
Amgen (AMGN) Stock After Horizon Deal And Strong Multi‑Year Gains Is Price Still Reasonable
- Tone
- Positive 82/100
- Event
- Deals and strategy
- Published
- 13 Jun 2026 01:30
- Source
- simplywall.st
Market source
Direct company coverage
Is Amgen Inc. (AMGN) A Good Stock To Buy Now?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 11 Jun 2026 15:25
- Source
- Market source
Market source
Direct company coverage
Is It Too Late To Consider Amgen (AMGN) After Its Strong Multi Year Share Price Run?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 09 Jun 2026 07:00
- Source
- Market source
Trefis
Direct company coverage
Is Amgen An Undervalued Stock Or Value Trap?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jun 2026 07:00
- Source
- Trefis
Traders Union
Direct company coverage
Amgen stock climbs as obesity drug research boosts future pipeline
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jun 2026 07:00
- Source
- Traders Union
Market source
Direct company coverage
Amgen Stock: Is AMGN Outperforming the Healthcare Sector?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 31 May 2026 07:00
- Source
- Market source
Traders Union
Direct company coverage
Amgen stock consolidates as earnings per share beats consensus
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 26 May 2026 07:00
- Source
- Traders Union
Market source
Direct company coverage
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 May 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Amgen’s US$300m Biologics Push And What It Means For AMGN Stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 May 2026 07:00
- Source
- Market source
PR Newswire
Direct company coverage
AMGEN ANNOUNCES ADDITIONAL $300 MILLION U.S. MANUFACTURING INVESTMENT, TOTALING NEARLY $2 BILLION OVER THE LAST YEAR
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 May 2026 07:00
- Source
- PR Newswire
Market source
Direct company coverage
Amgen (AMGN) Stock Up Since Jim Cramer Said “You Could Do a Lot Worse Than Amgen”
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Mar 2026 07:00
- Source
- Market source
Disruption Banking
Direct company coverage
Amgen: Biotech Pioneer’s Dow Jones Journey
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Aug 2025 07:00
- Source
- Disruption Banking
Clinical Trials Arena
Direct company coverage
Amgen speaks out about bone density concerns with obesity drug
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Nov 2024 08:00
- Source
- Clinical Trials Arena
marketscreener.com
Direct company coverage
FTC, States Agree On Path Forward For Amgen's Horizon Therapeutics Deal
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 11 Sep 2023 07:00
- Source
- marketscreener.com
marketscreener.com
Direct company coverage
Amgen Inc.: Financial Data Forecasts Estimates and Expectations | AMGN | US0311621009
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Jun 2023 15:21
- Source
- marketscreener.com
marketscreener.com
Direct company coverage
Amgen Inc.: Target Price Consensus and Analysts Recommendations | AMGN | US0311621009
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 18 Aug 2020 18:10
- Source
- marketscreener.com